What is the interpretation of a post-menopausal woman's lab results showing an estrogen level of 152.0, progesterone level of 3.6, Follicle-Stimulating Hormone (FSH) level of 7.8, free testosterone level of 1.0, other testosterone level of 3.0, elevated vitamin B12 level of 1812, and a vitamin D 25 level of 52.8?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lab Results Interpretation for Post-Menopausal Woman

These lab results are NOT consistent with typical post-menopause and suggest either exogenous hormone use, hormone-producing pathology, or laboratory error that requires immediate investigation.

Critical Findings Requiring Evaluation

Estrogen Level (152.0 pg/mL)

  • This estrogen level is abnormally elevated for a post-menopausal woman and falls within the range typical of pre-menopausal women during their follicular phase 1
  • Normal post-menopausal estradiol levels should be less than 50 pg/mL, with most women having levels between 10-30 pg/mL 1, 2
  • Effective hormone replacement therapy typically maintains estradiol levels between 35-100 pg/mL, but this is only appropriate for women actively taking HRT 1, 2
  • Possible explanations include:
    • Active use of estrogen replacement therapy (patches, pills, or creams) that the patient may not have disclosed 2
    • Estrogen-producing ovarian tumor or other hormone-secreting neoplasm requiring urgent imaging 3
    • Laboratory error requiring repeat testing 2

FSH Level (7.8 mIU/mL)

  • This FSH is inappropriately low for post-menopause 4
  • Post-menopausal women typically have FSH levels above 25-40 mIU/mL due to loss of ovarian feedback inhibition 4
  • The combination of high estrogen with low FSH suggests either:
    • Exogenous estrogen administration suppressing FSH through negative feedback 2
    • Estrogen-producing tumor providing feedback inhibition 3
    • The patient is not actually post-menopausal 4

Progesterone Level (3.6 ng/mL)

  • This progesterone level is elevated for post-menopause, where levels should typically be less than 1.0 ng/mL 4
  • This suggests either:
    • Active progestin/progesterone supplementation 5, 6
    • Progesterone-producing pathology (rare) 3
    • Laboratory error 2

Testosterone Levels

  • Free testosterone 1.0 ng/dL and total testosterone 3.0 ng/dL are within low-normal range for post-menopausal women 6
  • These levels do not require intervention unless the patient has specific symptoms of androgen deficiency 6
  • Testosterone supplementation in post-menopausal women is not FDA-approved and supported only by limited data with unknown long-term health effects 6

Vitamin Levels Assessment

Vitamin B12 (1812 pg/mL)

  • This B12 level is elevated above the typical reference range (200-900 pg/mL), but this is generally not clinically concerning 3
  • Elevated B12 can occur with:
    • B12 supplementation (most common and benign cause) 3
    • Rarely: liver disease, myeloproliferative disorders, or certain malignancies 3
  • No action needed unless other concerning symptoms are present 3

Vitamin D 25-OH (52.8 ng/mL)

  • This vitamin D level is optimal and requires no intervention 3, 6
  • Target vitamin D levels for post-menopausal women are 30-50 ng/mL, with levels above 50 ng/mL considered sufficient but not excessive 6
  • This level provides adequate support for bone health and calcium absorption 6
  • Maintain current vitamin D intake of 400-800 IU daily 6

Immediate Action Required

Order the following workup immediately:

  1. Confirm the patient is not taking any hormone replacement therapy (oral, transdermal, vaginal, or compounded preparations) 3, 5
  2. Repeat hormone panel to rule out laboratory error, including estradiol, FSH, LH, and progesterone 2
  3. Pelvic ultrasound to evaluate for ovarian masses or endometrial thickening 3
  4. Consider CT or MRI of pelvis if ultrasound shows concerning findings 3
  5. Endometrial biopsy if endometrial thickness exceeds 4-5 mm, given the elevated estrogen exposure 5, 6

Critical Caveat

Do not assume these results represent normal post-menopausal physiology - the combination of elevated estrogen, suppressed FSH, and elevated progesterone in a supposedly post-menopausal woman is pathologic until proven otherwise 4, 3. The most common explanation is undisclosed hormone use, but estrogen-producing tumors must be excluded urgently given the potential for malignancy 3.

References

Research

17 beta-estradiol for postmenopausal estrogen replacement therapy.

Obstetrical & gynecological survey, 1984

Research

Hormone replacement therapy in postmenopausal women.

The journal of medical investigation : JMI, 2003

Guideline

Hormone Replacement Therapy in Women Over 80

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hormone Replacement Therapy Initiation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hormone Replacement Therapy for Menopausal Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What hormone replacement therapy (HRT) and skin care products are recommended for postmenopausal women?
What are the safety considerations for Hormone Replacement Therapy (HRT) in postmenopausal women?
Can a 45-year-old symptomatic woman with perimenopausal hormone levels (Estradiol, Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH)) start Hormone Replacement Therapy (HRT) despite still experiencing menstrual periods?
Can a woman 15 years postmenopausal (post-menopause) initiate hormone replacement therapy (HRT)?
What are the recommendations for a patient considering stopping Hormone Replacement Therapy (HRT) 4 years post-menopause, primarily used for bone, brain, and heart health?
What is the best palliative medication for a patient with advanced terminal illness, such as cancer or Chronic Obstructive Pulmonary Disease (COPD), experiencing dyspnea and excessive secretions?
What should I do if I have a history of impaired renal concentration, recently developed symptoms of diabetes insipidus (DI) such as extreme thirst, abdominal pain, and temperature regulation issues over the last week, possibly triggered by lack of sleep, and I don't have desmopressin (DDAVP)?
What is the dose of ibuprofen (NSAID) for a 35kg child at 5mg/kg/day using 100mg/5ml formulation?
What hematocrit (Hct) drop levels indicate active bleeding in a patient?
Can pancreatic cancer cause excess insulin secretion?
Is my suspected diabetes insipidus (DI) causing my sleep disturbances and episodes of tachycardia after short periods of sleep?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.